Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast and Budesonide Combination in Seasonal Allergic Rhinitis
NCT04077892Phase 1Completed
- Sponsor
- Beijing Tongren Hospital
- Start
- Jun 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of montelukast in seasonal allergic rhinitis (SAR) (2 arms), sponsored by Beijing Tongren Hospital. Primary endpoint: Change of subjective Allergic Rhinitis symptoms at 14 days. Started Jun 2016; status: completed.
02
Drugs
montelukast
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT04077892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04077892.